December 3rd-5th, ASBM exhibited at the Midyear Meeting of the American Society of Health-system Pharmacists (ASHP) in Anaheim, CA. The meeting was attended by more than 25,000 pharmacists and is widely known in the pharmacy community as the largest professional gathering of pharmacists in the world.
ASBM was represented at the Midyear Meeting by its Advisory Board Chair, Philip Schneider, MS, FASHP, FFIP; who is a past president of ASHP.
At ASBM’s booth, Schneider and ASBM staff distributed information to attendees regarding key biosimilar policy issues which affect pharmacy practice. These include biosimilar approval, biosimilar naming, substitution policy at the state level, and the non-medical switching of patients’ biologic medicines by payers.
Educational videos targeted at pharmacists were also shown at the ASBM booth during the three-day exhibition. These included a video featuring Schneider and fellow ASBM Advisory Board member Ron Jordan, Dean of the Chapman University College of Pharmacy and past president of the American Pharmacist Association (APhA).
ASBM’s recently-released pharmacist videos on naming, interchangeability and substitution, and non-medical switching were also shown.
Read more about the ASHP Midyear Meeting here.